Doctor profile · Federal record
Dr. Pedram Ghasri, M.D.
Dermatology Physician (CMS: Dermatology) · Tarzana, CA
- NPI 1639429178
- Accepts Medicare
- MIPS 95.0 / 100 · 2023
- 15 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
18555 Ventura Blvd
Tarzana, CA 913564191
(818) 344-3376
Credentials & registration
- NPI registered
- September 2012 — 14 yrs on file
- Profile last updated
- March 14, 2024
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- California #CA123798
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1639429178. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,776
Distinct HCPCS
10
Medicare allowed
$1,095,312
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,694 | 317 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,266 | 699 | $141 | |
Q4196 |
Puraply am, per square centimeter | 1,080 | 24 | $105 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 868 | 475 | $100 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 551 | 345 | $195 | |
17000 |
Destruction of precancer skin growth, 1 growth | 546 | 388 | $60 | |
11102 |
Biopsy of related skin growth, first growth | 530 | 442 | $105 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 397 | 397 | $123 | |
11103 |
Biopsy of related skin growth, each additional growth | 234 | 164 | $58 | |
17111 |
Destruction of skin growth, 15 or more growths | 222 | 163 | $153 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 249. This provider delivers 39× the peer median.Open Payments
Industry payments received
All-time total
$2,681
Transactions
130
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 32 | $444.87 | |
| Janssen Biotech, Inc. | 8 | $256.49 | |
| GENZYME CORPORATION | 7 | $211.32 | |
| Dermavant Sciences, Inc. | 16 | $206.89 | |
| Regeneron Healthcare Solutions, Inc. | 7 | $199.25 | |
| Incyte Corporation | 12 | $167.02 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $161.53 | |
| Arcutis Biotherapeutics, Inc. | 9 | $138.39 | |
| PFIZER INC. | 11 | $131.71 | |
| Amgen Inc. | 5 | $108.80 | |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $90.73 | |
| Lilly USA, LLC | 3 | $88.43 | |
| Journey Medical Corporation | 2 | $65.71 | |
| Organogenesis Inc. | 2 | $64.85 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58.78 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,422
Patients
1,263
Total drug cost
$254,103
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 489 | 293 | $5,026 |
| Ketoconazole | Generic | 486 | 208 | $9,835 |
| Clobetasol Propionate | Generic | 387 | 212 | $45,050 |
| Hydrocortisone | Generic | 186 | 111 | $1,781 |
| Mupirocin | Generic | 166 | 114 | $1,824 |
| Doxycycline Hyclate | Generic | 135 | 84 | $3,846 |
| Betamethasone Dipropionate | Generic | 96 | 51 | $5,813 |
| Finasteride | Generic | 93 | 28 | $1,512 |
| Minoxidil | Generic | 88 | 26 | $887 |
| Nystatin | Generic | 71 | 31 | $1,504 |
Frequently asked questions
What is Dr. Pedram Ghasri's medical specialty?
Dr. Pedram Ghasri practices Dermatology Physician in Tarzana, CA.
Where does Dr. Pedram Ghasri practice?
Dr. Pedram Ghasri practices at 18555 Ventura Blvd, Tarzana, CA 913564191. Office phone: 8183443376.
What is Dr. Pedram Ghasri's NPI?
Dr. Pedram Ghasri's National Provider Identifier (NPI) is 1639429178, issued by NPPES.
Does Dr. Pedram Ghasri accept Medicare assignment?
Yes. Dr. Pedram Ghasri accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Pedram Ghasri commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Puraply am, per square centimeter (HCPCS Q4196). Source: CMS Medicare Physician & Other Practitioners file.